Paclitaxel (Taxol Equivalent) - for use in research only
Paclitaxel (Taxol Equivalent) - for use in research only
Invitrogen™

Paclitaxel (Taxol Equivalent) - for use in research only

Invitrogen offers paclitaxel for research purposes only at a purity of >98% by HPLC. Paclitaxel, formerly referred to as taxolRead more
Have Questions?
Catalog NumberQuantity
P34565 mg
Catalog number P3456
Price (EUR)
170,20
Special offer
Online exclusive
Ends: 15-Mar-2026
230,00
Save 59,80 (26%)
Each
Add to cart
Quantity:
5 mg
Price (EUR)
170,20
Special offer
Online exclusive
Ends: 15-Mar-2026
230,00
Save 59,80 (26%)
Each
Add to cart
Invitrogen offers paclitaxel for research purposes only at a purity of >98% by HPLC. Paclitaxel, formerly referred to as taxol in some scientific literature, is the approved generic name for the anticancer pharmaceutical Taxol (a registered trademark of Bristol-Myers Squibb Co). Paclitaxel promotes tubulin assembly, producing aggregates that cannot be depolymerized by dilution, calcium ions, cold or a number of microtubule-disrupting drugs. Cultured cells treated with paclitaxel are blocked in the G2 and M phases of the cell cycle.
For Research Use Only. Not for use in diagnostic procedures.
Specifications
FormLyophilized
InhibitorsCytoskeletal Inhibitor
Quantity5 mg
Shipping ConditionRoom Temperature
Specific Inhibit or TargetTubulin
Product TypePaclitaxel
Unit SizeEach
Contents & Storage
Store in freezer -5°C to -30°C.

Citations & References (122)

Citations & References
Abstract
A phase II study of taxol in patients with malignant melanoma.
Authors:Einzig AI, Hochster H, Wiernik PH, Trump DL, Dutcher JP, Garowski E, Sasloff J, Smith TJ
Journal:Invest New Drugs
PubMed ID:1673965
Based on results of a phase I study demonstrating antitumor activity of taxol in patients with melanoma, 34 patients with documented metastatic melanoma received taxol, 250 mg/m2, as a 24-hours infusion, repeated every 21 days, in this phase II study. All patients received premedication with dexamethasone, diphenhydramine and cimetidine. Four ... More
Regulation of melanosome movement in the cell cycle by reversible association with myosin V.
Authors:Rogers SL, Karcher RL, Roland JT, Minin AA, Steffen W, Gelfand VI
Journal:J Cell Biol
PubMed ID:10491390
'Previously, we have shown that melanosomes of Xenopus laevis melanophores are transported along both microtubules and actin filaments in a coordinated manner, and that myosin V is bound to purified melanosomes (Rogers, S., and V.I. Gelfand. 1998. Curr. Biol. 8:161-164). In the present study, we have demonstrated that myosin V ... More
Chemical subdomains within the kinetochore domain of isolated CHO mitotic chromosomes.
Authors:Wordeman L, Steuer ER, Sheetz MP, Mitchison T
Journal:J Cell Biol
PubMed ID:1830054
'We have used indirect immunofluorescence in combination with correlative EM to subdivide the mammalian kinetochore into two domains based on the localization of specific antigens. We demonstrate here that the fibrous corona on the distal face of the kinetochore plate contains tubulin (previously shown by Mitchison, T. J., and M. ... More
Targeted disruption of mouse conventional kinesin heavy chain, kif5B, results in abnormal perinuclear clustering of mitochondria.
Authors:Tanaka Y, Kanai Y, Okada Y, Nonaka S, Takeda S, Harada A, Hirokawa N
Journal:Cell
PubMed ID:9657148
'Mouse kif5B gene was disrupted by homologous recombination. kif5B-/- mice were embryonic lethal with a severe growth retardation at 9.5-11.5 days postcoitum. To analyze the significance of this conventional kinesin heavy chain in organelle transport, we studied the distribution of major organelles in the extraembryonic cells. The null mutant cells ... More
Cdc42-interacting protein 4 mediates binding of the Wiskott-Aldrich syndrome protein to microtubules.
Authors:Tian L, Nelson DL, Stewart DM
Journal:J Biol Chem
PubMed ID:10713100
'The Wiskott-Aldrich syndrome is an inherited X-linked immunodeficiency characterized by thrombocytopenia, eczema, and a tendency toward lymphoid malignancy. Lymphocytes from affected individuals have cytoskeletal abnormalities, and monocytes show impaired motility. The Wiskott-Aldrich syndrome protein (WASP) is a multi-domain protein involved in cytoskeletal organization. In a two-hybrid screen, we identified the ... More